Literature DB >> 22118048

Pharmacogenomics of cytarabine in childhood leukemia.

Jatinder K Lamba.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22118048     DOI: 10.2217/pgs.11.148

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  4 in total

1.  Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.

Authors:  Eric R Gamazon; Jatinder K Lamba; Stanley Pounds; Amy L Stark; Heather E Wheeler; Xueyuan Cao; Hae K Im; Amit K Mitra; Jeffrey E Rubnitz; Raul C Ribeiro; Susana Raimondi; Dario Campana; Kristine R Crews; Shan S Wong; Marleen Welsh; Imge Hulur; Lidija Gorsic; Christine M Hartford; Wei Zhang; Nancy J Cox; M Eileen Dolan
Journal:  Blood       Date:  2013-03-28       Impact factor: 22.113

2.  Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine‑induced death of leukaemia cells.

Authors:  Caroline Palmeira dos Santos; Gustavo J S Pereira; Christiano M V Barbosa; Aron Jurkiewicz; Soraya S Smaili; Claudia Bincoletto
Journal:  J Cancer Res Clin Oncol       Date:  2014-06       Impact factor: 4.553

3.  Comprehensive Ara-C SNP score predicts leukemic cell intracellular ara-CTP levels in pediatric acute myeloid leukemia patients.

Authors:  Abdelrahman H Elsayed; Xueyuan Cao; Kristine R Crews; Varsha Gandhi; William Plunkett; Jeffrey E Rubnitz; Raul C Ribeiro; Stanley B Pounds; Jatinder K Lamba
Journal:  Pharmacogenomics       Date:  2018-08-08       Impact factor: 2.533

4.  Evaluation of the impact of single-nucleotide polymorphisms on treatment response, survival and toxicity with cytarabine and anthracyclines in patients with acute myeloid leukaemia: a systematic review protocol.

Authors:  Taynah Cascaes Puty; Jonathan Souza Sarraf; Tabata Cristina Do Carmo Almeida; Valter Cordeiro Barbosa Filho; Luis Eduardo Werneck de Carvalho; Fernando Luiz Affonso Fonseca; Fernando Adami
Journal:  Syst Rev       Date:  2019-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.